Atlas Trials

Irreversible Electroporation(IRE) For Unresectable Head and Neck Neoplasms

Clinical trial NCT02335112 · COMPLETED

Trial details

NCT number
NCT02335112
Sponsor
Fuda Cancer Hospital, Guangzhou
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Head and Neck Neoplasms
Start date
2015-01-01
Primary completion
2020-12-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.